US 8029788
Variants of humanized anti-carcinoma MAb CC49
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 8029788 (Variants of humanized anti-carcinoma MAb CC49) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K49/0002, A61K51/1045